JohnJFioreMD

PubMed

• 39 citations
  Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancer.
  Justin Jee, Emily S Lebow, Randy Yeh, Jeeban P Das, Azadeh Namakydoust, Paul K Paik, Jamie E Chaft, Gowtham Jayakumaran, A Rose Brannon, Ryma Benayed, Ahmet Zehir, Mar...> ;Nature Medicine. 2022 Nov 1
• 8 citations
  A Phase II Trial of Albumin-Bound Paclitaxel and Gemcitabine in Patients with Newly Diagnosed Stage IV Squamous Cell Lung Cancers
  Paul K. Paik, Rachel Kim, Linda Ahn, Andrew J. Plodkowski, Ai Ni, Mark T.A. Donoghue, Philip Jonsson, Miguel A. Villalona-Calero, Kenneth K. Ng, Daniel C. McFarland, J...> ;Clinical Cancer Research. 2020 Apr 15
• 94 citations
  Large Cell Neuroendocrine Carcinoma of the Lung: Clinico-Pathologic Features, Treatment, and Outcomes
  Jarushka Naidoo, Maria Laureana Santos-Zabala, Tunc Iyriboz, Kaitlin M. Woo, Camelia S. Sima, John J. Fiore, Mark G. Kris, Gregory J. Riely, Piro Lito, Afsheen Iqbal, ...> ;Clinical Lung Cancer. 2016 Sep 1
• 4 citations
  Phase II Study of a Non-Platinum–Containing Doublet of Paclitaxel and Pemetrexed with Bevacizumab as Initial Therapy for Patients with Advanced Lung Adenocarcinomas
  Maria Catherine Pietanza, Matthew D. Hellmann, John J. Fiore, Stephanie Smith-Marrone, Ethan Basch, Lawrence H. Schwartz, Michelle S. Ginsberg, Marwan Shouery, Samanth...> ;Journal of Thoracic Oncology. 2016 Jun 1
• 115 citations
  Phase II Trial of Temozolomide in Patients with Relapsed Sensitive or Refractory Small Cell Lung Cancer, with Assessment of Methylguanine-DNA Methyltransferase as a Po...
  M. Catherine Pietanza, Kyuichi Kadota, Kety Huberman, Camelia S. Sima, John J. Fiore, Dyana K. Sumner, William D. Travis, Adriana Heguy, Michelle S. Ginsberg, Andrei I...> ;Clinical Cancer Research. 2012 Feb 15
• 100 citations
  Phase I/II Trial of Weekly Intravenous 130-nm Albumin-Bound Paclitaxel As Initial Chemotherapy in Patients With Stage IV Non–Small-Cell Lung Cancer
  Naiyer A. Rizvi, Gregory J. Riely, Christopher G. Azzoli, Vincent A. Miller, Kenneth K.-S. Ng, John J. Fiore, Gloria Chia, Martin Brower, Robert T. Heelan, Michael J. ...> ;Journal of Clinical Oncology. 2008 Feb 1
• 5 citations
  An overview of lung cancer.
  Sharona Sachs, John J Fiore> ;Respiratory Care Clinics of North America. 2003 Mar 1
• 31 citations
  Phase I chemotherapy study of biochemical modulation of folinic acid and fluorouracil by gemcitabine in patients with solid tumor malignancies.
  Stefan Madajewicz, Patricia Hentschel, P. Burns, R. Caruso, John J. Fiore, M. Fried, H. Malhotra, S. Ostrow, Steven Sugarman, Michael V. Viola> ;Journal of Clinical Oncology. 2000 Oct 20
• 4 citations
  Actual 5-year survival of patients with stage IIIB breast carcinoma: phase II trial of methotrexate, vinblastine, adriamycin, cisplatin, and folinic acid.
  Stefan Madajewicz, Daniele Matei, Patricia Hentschel, Andrzej P. Kudelka, William G. Abel, John J. Fiore, Noshir A. DaCosta, Lakshmi Pendyala> ;Cancer Investigation. 1999 Jan 1
• 8 citations
  Preclinical and clinical evaluation of 5‐fluorouracil biochemical modulation with folinic acid and hydroxyurea for patients with colorectal carcinoma
  Daniele Matei, Nabil Hagag, Stefan Madajewicz, Naveed Chowhan, Patricia Hentschel, Louis Avvento, Patricia Burns, John J. Fiore, William Lipera, Hosein Zarrabi> ;Cancer. 1995 Oct 15
• 8 citations
  Proteinase-alpha 2 macroglobulin complexes are not increased in plasma of patients with cancer.
  Stanley Zucker, Rita M. Lysik, Mohamed H. Zarrabi, John J. Fiore, Dudley K. Strickland> ;International Journal of Cancer. 1991 May 30
• 35 citations
  Metastatic adenocarcinomas of unknown primary site. Prognostic variables and treatment results.
  Susan A. Kambhu, David P. Kelsen, John J. Fiore, Donna Niedzwiecki, Douglas Chapman, Vincent Vinciguerra, Richard Rosenbluth> ;American Journal of Clinical Oncology. 1990 Feb 1
• 2 citations
  Clinical experience with 5-FU/DDP +/- OHDW combination chemotherapy in patients with advanced colorectal carcinoma.
  Stefan Madajewicz, John J. Fiore, Zarrabi Mh> ;Advances in Experimental Medicine and Biology. 1988 Jan 1
• 4 citations
  Phase II trial of esorubicin in patients with advanced non-small cell lung cancer.
  Mark G. Kris, Richard J. Gralla, Burke Mt, John J. Fiore, David P. Kelsen, Linda D. Marks, Robert T. Heelan> ;Cancer Treatment Reports. 1987 Jul 1
• 12 citations
  Phase II trial of etoposide in APUD tumors.
  David P. Kelsen, John J. Fiore, Robert T. Heelan, Emily H. Cheng, Magill G> ;Cancer Treatment Reports. 1987 Mar 1
• 5 citations
  Systemic absorption of a leucovorin mouth wash: a pharmacologic study.
  John J. Fiore, Nancy E. Kemeny, Bipin M. Mehta, Nancy L. Geller, Dennis D. Grossano, Donald J. Murphy> ;Cancer Investigation. 1987 Jan 1
• 192 citations
  Frequency and prognostic importance of pretreatment clinical characteristics in patients with advanced non-small-cell lung cancer treated with combination chemotherapy.
  Joe O'Connell, Mark G. Kris, Richard J. Gralla, Susan Groshen, Andrea Trust, John J. Fiore, David P. Kelsen, Robert T. Heelan, Robert B. Golbey> ;Journal of Clinical Oncology. 1986 Nov 1
• 3 citations
  Phase II trial of esorubicin in patients with advanced colorectal carcinoma.
  John J. Fiore, Nancy E. Kemeny, Raymond, Young C> ;Cancer Treatment Reports. 1986 Oct 1
• 54 citations
  Trial of the combination of mitomycin, vindesine, and cisplatin in patients with advanced non-small cell lung cancer.
  Mark G. Kris, Richard J. Gralla, M. S. Wertheim, David P. Kelsen, Joe O'Connell, Burke Mt, John J. Fiore, I. R. Cibas, Robert T. Heelan> ;Cancer Treatment Reports. 1986 Sep 1
• 59 citations
  Consecutive dose-finding trials adding lorazepam to the combination of metoclopramide plus dexamethasone: improved subjective effectiveness over the combination of dip...
  Mark G. Kris, Richard J. Gralla, Rebecca A. Clark, Leslie B. Tyson, John J. Fiore, David P. Kelsen, Susan Groshen> ;Cancer Treatment Reports. 1985 Nov 1
• 9 citations
  Phase II trial of oral 4-demethoxydaunorubicin in patients with non-small cell lung cancer.
  Mark G. Kris, Richard J. Gralla, David P. Kelsen, Ephraim S. Casper, Burke Mt, John J. Fiore, I. R. Cibas, Robert T. Heelan> ;American Journal of Clinical Oncology. 1985 Oct 1
• 16 citations
  Adenocarcinoma of unknown primary origin: treatment with vindesine and doxorubicin.
  John J. Fiore, David P. Kelsen, Richard J. Gralla, Ephraim S. Casper, Magill G, Emily H. Cheng, Ochoa M> ;Cancer Treatment Reports. 1985 Jun 1
• 23 citations
  Trial of vindesine plus mitomycin in stage-3 non-small cell lung cancer. An active regimen for outpatient treatment.
  Mark G. Kris, Richard J. Gralla, David P. Kelsen, Ephraim S. Casper, M. Thomasine Burke, John J. Fiore, I. R. Cibas, Robert T. Heelan> ;Chest. 1985 Mar 1
• 20 citations
  Pharmacologic Treatment of Chemotherapy-Induced Nausea and Vomiting
  John J. Fiore, Richard J. Gralla> ;Cancer Investigation. 1984 Jan 1
• Join now to see all